Rossari Biotech Limited

ROSSARIPriced above fair value

A 6-pillar fundamental profile. Each pillar scored 0–10.

5.7/10 composite
Prism for ROSSARI.NS: composite 5.7 of 10, verdict Priced above fair valuePULSEQUALITYMOATSAFETYGROWTHVALUE0.00.00.00.00.00.0

Pulse

8.0 · Positive

Analyst revision trend (fallback)

Pulse tracks recent momentum in price, analyst revisions, and news sentiment. Higher means stronger near-term tailwinds.

Quality

5.3 · Moderate

Piotroski 5/9, ROCE 14.9%

Quality captures profitability, return on capital, and earnings consistency. Higher means a better business.

Moat

7.0 · Moderate

Moderate moat

Moat estimates durable competitive advantages — brand, scale, switching costs. Higher means more defensible.

Safety

8.3 · Strong

D/E 0.28, Int cov 11.4x

Safety looks at balance-sheet strength, leverage, and cash generation. Higher means lower financial risk.

Growth

4.1 · Weak

Rev CAGR 12.0%, EPS CAGR -26.4%

Growth reflects revenue and earnings expansion over recent years. Higher means faster compounding.

Value

3.9 · Weak

MoS -12%, P/E 20.3

Value measures whether the stock is cheap relative to its intrinsic worth. Higher is cheaper.

Compare with another stock

Overlay ROSSARI's prism against a peer.

Share this prism

Share on XWhatsApp

Get the full analysis

Interactive DCF, sensitivity, peer comparison, and AI summary for ROSSARI.

Full analysis →

Model estimate. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.